4.7 Article

Asthma in the elderly: Current understanding and future research needs-a report of a National Institute on Aging (NIA) workshop

Journal

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
Volume 128, Issue 3, Pages S4-S24

Publisher

MOSBY-ELSEVIER
DOI: 10.1016/j.jaci.2011.06.048

Keywords

Aging; airway; allergy; asthma; elderly; immune mechanisms; immunosenescence

Funding

  1. National Institute on Aging
  2. GlaxoSmithKline
  3. Genentech
  4. Novartis
  5. Pfizer
  6. Boehringer Ingelheim
  7. Forest
  8. Merck
  9. Sanofi Pasteur
  10. NIH
  11. American Lung Association
  12. National Heart, Lung, and Blood Institute/NIH
  13. Agency for Healthcare Research and Quality

Ask authors/readers for more resources

Asthma in the elderly is underdiagnosed and undertreated, and there is a paucity of knowledge on the subject. The National Institute on Aging convened this workshop to identify what is known and what gaps in knowledge remain and suggest research directions needed to improve the understanding and care of asthma in the elderly. Asthma presenting at an advanced age often has similar clinical and physiologic consequences as seen with younger patients, but comorbid illnesses and the psychosocial effects of aging might affect the diagnosis, clinical presentation, and care of asthma in this population. At least 2 phenotypes exist among elderly patients with asthma; those with longstanding asthma have more severe airflow limitation and less complete reversibility than those with late-onset asthma. Many challenges exist in the recognition and treatment of asthma in the elderly. Furthermore, the pathophysiologic mechanisms of asthma in the elderly are likely to be different from those seen in young asthmatic patients, and these differences might influence the clinical course and outcomes of asthma in this population. (J Allergy Clin Immunol 2011;128:S4-24.)

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available